We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$64.7B
AUM Growth
+$5.24B
Cap. Flow
+$2.36B
Cap. Flow %
3.65%
Top 10 Hldgs %
20.54%
Holding
3,821
New
235
Increased
1,962
Reduced
1,317
Closed
186

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$155M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$145M
3
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$113M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$58M
5
CPA icon
Copa Holdings
CPA
+$49.3M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$40.1M
2
T icon
AT&T
T
+$28M
3
FTXO icon
First Trust Nasdaq Bank ETF
FTXO
+$24.3M
4
TTE icon
TotalEnergies
TTE
+$23.7M
5
WMT icon
Walmart Inc
WMT
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 10.68%
2 Financials 9.21%
3 Healthcare 8.48%
4 Industrials 6.92%
5 Consumer Discretionary 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MXWL
3476
DELISTED
Maxwell Technologies Inc
MXWL
$43K ﹤0.01%
+12,360
New +$50K
GSV
3477
DELISTED
Gold Standard Ventures Corp.
GSV
$42K ﹤0.01%
24,175
-2,000
-8% -$3.15K
GILD icon
3478
CALL
Gilead Sciences
GILD
$165B
$40K ﹤0.01%
+37,200
New +$2.81M
TCON
3479
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$40K ﹤0.01%
97
-44
-31% -$20.4K
AMPE
3480
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$40K ﹤0.01%
261
+56
+27% +$23.4K
ABBV icon
3481
CALL
AbbVie
ABBV
$434B
$39K ﹤0.01%
111,000
-27,200
-20% -$2.58M
AVP
3482
DELISTED
Avon Products, Inc.
AVP
$39K ﹤0.01%
17,817
-1,196
-6% -$2.2K
KERX
3483
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$38K ﹤0.01%
11,217
-1,454
-11% -$5.24K
MO icon
3484
CALL
Altria Group
MO
$111B
$37K ﹤0.01%
36,700
+8,800
+32% +$522K
WHWK
3485
Whitehawk Therapeutics
WHWK
$261M
$37K ﹤0.01%
+800
New +$44.9K
VIVS
3486
VivoSim Labs
VIVS
$1.29M
$37K ﹤0.01%
135
– –
ESRX
3487
CALL
DELISTED
Express Scripts Holding Company
ESRX
$37K ﹤0.01%
+11,100
New +$946K
DHF
3488
BNY Mellon High Yield Strategies Fund
DHF
$173M
$36K ﹤0.01%
11,088
– –
EMX
3489
DELISTED
EMX Royalty
EMX
$36K ﹤0.01%
29,449
– –
AVEO
3490
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$34K ﹤0.01%
+1,020
New +$26.2K
BBY icon
3491
CALL
Best Buy
BBY
$17.3B
$33K ﹤0.01%
21,800
+400
+2% +$31K
CB icon
3492
CALL
Chubb
CB
$134B
$33K ﹤0.01%
88,400
+49,000
+124% +$6.63M
DHY
3493
Credit Suisse High Yield Credit Fund
DHY
$240M
$33K ﹤0.01%
12,585
– –
LITE icon
3494
CALL
Lumentum
LITE
$64.6B
$33K ﹤0.01%
31,400
-700
-2% -$41.9K
NMM icon
3495
Navios Maritime Partners
NMM
$2.24B
$32K ﹤0.01%
1,224
– –
PER
3496
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$32K ﹤0.01%
12,047
-125
-1% -$331
CVX icon
3497
CALL
Chevron
CVX
$381B
$31K ﹤0.01%
66,900
-12,000
-15% -$1.46M
TT icon
3498
CALL
Trane Technologies
TT
$105B
$31K ﹤0.01%
+11,300
New +$1.1M
IDXG
3499
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$31K ﹤0.01%
2,000
– –
MUR icon
3500
CALL
Murphy Oil
MUR
$5.11B
$30K ﹤0.01%
+10,400
New +$330K
138 139
140
141 142

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q3 2018 Portfolio in Review

As of Q3 2018, Raymond James & Associates held 3,821 positions worth $64.7B, up 8.8% from $59.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates deployed $2.36B of net new capital in Q3 2018, opening 235 new positions and adding to 1,962 existing holdings. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Sanofi, an estimated $40.1M trimmed.

  • Raymond James & Associates's largest Q3 2018 buy was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q3 2018, an estimated $155M increase.
  • Raymond James & Associates's biggest Q3 2018 reduction was Sanofi, cutting an estimated $40.1M.
  • Raymond James & Associates fully exited Abaxis Inc in Q3 2018, selling an estimated $10.5M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $64.7B portfolio in Q3 2018.
  • Raymond James & Associates opened 235 new positions and closed 186 in Q3 2018.
  • Raymond James & Associates's portfolio value rose 8.8% quarter-over-quarter to $64.7B.

Based on Raymond James & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.